Steven Cohen Cytek Biosciences, Inc. Transaction History

Point72 Asset Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$8.44 - $13.47 $6.86 Million - $10.9 Million	-812,662 Closed	0 $0
Q4 2022 Feb 14, 2023	BUY	$9.71 - $15.86 $1.35 Million - $2.21 Million	139,175 Added 20.66%	812,662 $8.3 Million
Q3 2022 Nov 14, 2022	SELL	$10.96 - $15.45 $9.45 Million - $13.3 Million	-862,592 Reduced 56.16%	673,487 $9.91 Million
Q2 2022 Aug 15, 2022	BUY	$7.41 - $11.56 $6.71 Million - $10.5 Million	905,079 Added 143.44%	1,536,079 $16.5 Million
Q1 2022 May 16, 2022	BUY	$9.89 - $17.25 $6.24 Million - $10.9 Million	631,000 New	631,000 $6.8 Million

121

72.5M

13.2K

31.2K

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $751M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.